Clinical Outcome in Uveitis
This trial is active, not recruiting.
|Sponsor||Moorfields Eye Hospital NHS Foundation Trust|
|Start date||September 2011|
|End date||December 2018|
|Trial size||1500 participants|
|Trial identifier||NCT01983488, LIGS10201|
This study is aimed at investigating the long term clinical outcome of patients with uveitis.
Patient with a clinical diagnosis of Uveitis.
Best Corrected Visual Acuity
time frame: up to 10 years
Causes of visual loss
time frame: First follow-up, years 1,2,5,10, Final follow-up
All participants of any age.
Inclusion Criteria: - Clinical Diagnosis of Uveitis. Exclusion Criteria: - No follow-up data.
|Official title||Clinical Outcome and Causes of Visual Loss in Uveitis|
|Principal investigator||Sue Lightman, PhD,FRCOphth|
|Description||Patients will be included if they are treated for uveitis and have had repeat follow-up. Data will be gathered from the entire length of the patients follow-up. The main outcome measures will be: Change from baseline of Best corrected visual acuity (BCVA)at 10 years Causes of vision loss (≤6/15, VL) and severe vision loss (≤6/60, SVL) at 10 years Number of clinical visits at 10 years.|
Call for more information